The use and impact of cognitive enhancers among university students: a systematic review

S Sharif, A Guirguis, S Fergus, F Schifano - Brain sciences, 2021 - mdpi.com
Introduction: Cognitive enhancers (CEs), also known as “smart drugs”,“study aids” or
“nootropics” are a cause of concern. Recent research studies investigated the use of CEs …

[HTML][HTML] Systematic review: nonmedical use of prescription stimulants: risk factors, outcomes, and risk reduction strategies

SV Faraone, AL Rostain, CB Montano, O Mason… - Journal of the American …, 2020 - Elsevier
Objective To review all literature on the nonmedical use (NMU) and diversion of prescription
stimulants to better understand the characteristics, risk factors, and outcomes of NMU and to …

Trends in the prevalence and incidence of attention-deficit/hyperactivity disorder among adults and children of different racial and ethnic groups

W Chung, SF Jiang, D Paksarian, A Nikolaidis… - JAMA network …, 2019 - jamanetwork.com
Importance An increasing prevalence of adult attention-deficit/hyperactivity disorder (ADHD)
diagnosis and treatment has been reported in clinical settings and administrative data in the …

Benefits and harms of 'smart drugs'(nootropics) in healthy individuals

F Schifano, V Catalani, S Sharif, F Napoletano… - Drugs, 2022 - Springer
Abstract 'Smart drugs'(also known as 'nootropics' and 'cognitive enhancers'[CEs]) are being
used by healthy subjects (ie students and workers) typically to improve memory, attention …

Psychedelic microdosing: prevalence and subjective effects

LP Cameron, A Nazarian, DE Olson - Journal of psychoactive …, 2020 - Taylor & Francis
Anecdotal reports suggest that the administration of sub-hallucinogenic doses of
psychedelic compounds on a chronic, intermittent schedule–a practice known as …

[HTML][HTML] Smart drugs and neuroenhancement: what do we know?

M Esposito, G Cocimano, F Ministrieri… - Frontiers in Bioscience …, 2021 - imrpress.com
Introduction: Smart drugs are among the most common drugs used by students. It is
estimated that they are second in incidence after cannabis. Although they are usually used …

On pharmacological neuroenhancement as part of the new neurorights' pioneering legislation in Chile: a perspective

MI Cornejo-Plaza, C Saracini - Frontiers in psychology, 2023 - frontiersin.org
The so-called neurorights are emerging human rights, or rather reconfigurations of already
existing human rights, seeking to address the impact of the possible misuse of …

Nootropic drugs: methylphenidate, modafinil and piracetam–population use trends, occurrence in the environment, ecotoxicity and removal methods–a review

W Wilms, M Woźniak-Karczewska, PFX Corvini… - Chemosphere, 2019 - Elsevier
Pharmaceuticals which originally were designed to treat people with neurological and
psychiatric conditions, eg Alzheimer's disease or attention deficit hyperactivity disorder …

Pharmacological neuroenhancement: current aspects of categorization, epidemiology, pharmacology, drug development, ethics, and future perspectives

J Daubner, MI Arshaad, C Henseler… - Neural …, 2021 - Wiley Online Library
Recent pharmacoepidemiologic studies suggest that pharmacological neuroenhancement
(pNE) and mood enhancement are globally expanding phenomena with distinctly different …

Potential risk groups and psychological, psychosocial, and health behavioral predictors of pharmacological neuroenhancement among university students in Germany

S Heller, AN Tibubos, TA Hoff, AM Werner… - Scientific reports, 2022 - nature.com
Aiming to develop and implement intervention strategies targeting pharmacological
neuroenhancement (PN) among university students more specifically, we (1) assessed the …